| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/27/2006 | US20060088547 Expression, purification and uses of a Plasmodium falciparum liver stage antigen 1 polypeptide |
| 04/27/2006 | US20060088546 Antigens for raising an immune response against rickettsieae and ehrlichieae pathogens |
| 04/27/2006 | US20060088544 Methods of preparation and composition of peptide constructs useful for treatment of autoimmune and transplant related host versus graft conditions |
| 04/27/2006 | US20060088543 Use of passive myostatin immunization |
| 04/27/2006 | US20060088537 Protein involved in cancer |
| 04/27/2006 | US20060088536 Therapeutic drug using antibody-presenting hollow protein nanoparticles and hollow protein nanoparticles |
| 04/27/2006 | US20060088535 Method for enhancing long-term memory in a subject and uses thereof |
| 04/27/2006 | US20060088532 Lymphatic and blood endothelial cell genes |
| 04/27/2006 | US20060088527 Lung tumor polynucleotides, polypeptides, fusion proteins, antigen presenting cells, T-cells and vaccines containing the polypeptide and an immunostimulant; genetic vaccines; improved early detection |
| 04/27/2006 | US20060088520 Antigen presenting cell targeting conjugate, an antigen presenting cell contacted with such conjugate, their use for vaccination or as medicament, and methods for their production or generation |
| 04/27/2006 | US20060088510 Promotes the growth and differentiation of cells; attached therapeutic agents can be used to promote this process and the gel along with the growing cells can be implanted at a site in vivo where tissue repair is needed; membranes can be used for culturing cells in vitro; delivering drugs in vitro |
| 04/27/2006 | DE102004051014A1 Chemisch modifizierte Peptidanaloga Chemically modified peptide analogs |
| 04/27/2006 | DE102004011663B4 Erythropoietin-Flüssigformulierung Erythropoietin liquid formulation |
| 04/27/2006 | CA2585342A1 Method for separating keratinous proteins from materials |
| 04/27/2006 | CA2584862A1 Autocrine growth factor receptors and methods |
| 04/27/2006 | CA2584753A1 Method for controlling insects of the order diptera using a bacillus thuringiensis strain |
| 04/27/2006 | CA2584661A1 Increased wax production in plants |
| 04/27/2006 | CA2584625A1 Ami-deficient streptococcus thermophilus strains with reduced post-acidification |
| 04/27/2006 | CA2584518A1 Device and method for removing heavy metals from contaminated samples with membranes comprising purified metallothionein |
| 04/27/2006 | CA2584517A1 Method for producing l-amino acids using bacteria of the enterobacteriaceae family |
| 04/27/2006 | CA2584407A1 Method for the isolation of haptoglobin |
| 04/27/2006 | CA2584263A1 Chemically modified peptide analogs |
| 04/27/2006 | CA2584078A1 Soluble zcytor21, anti-zcytor21 antibodies and binding partners and methods of using in inflammation |
| 04/27/2006 | CA2584048A1 Multi-domain amphipathic helical peptides and methods of their use |
| 04/27/2006 | CA2583937A1 Chimeric protein |
| 04/27/2006 | CA2583138A1 Process for producing natural immunobiotic extract and uses thereof |
| 04/27/2006 | CA2576643A1 Screening assays for inhibitors of a staphylococcus aureus siderophore |
| 04/26/2006 | EP1650562A1 Method of screening useful protein |
| 04/26/2006 | EP1650310A1 Recombinant avian adenovirus vector |
| 04/26/2006 | EP1650309A1 Lentiviral vectors for the preparation of immunotherapeutical compositions |
| 04/26/2006 | EP1650308A1 Nucleic acid sequences encoding proteins capable of associating into a virus-like particle |
| 04/26/2006 | EP1650307A2 Methods for making recombinant proteins using apoptosis inhibitors |
| 04/26/2006 | EP1650304A2 Cloning and recombinant production of vespid venom phospholipase and immunological therapies based thereon |
| 04/26/2006 | EP1650303A2 Method for generating a substracted cDNA library and uses of the generated library |
| 04/26/2006 | EP1650302A1 Protein capable of deposition onto extracellular matrix |
| 04/26/2006 | EP1650301A1 Gene imparting redifferentiation ability of plant and utilization of the same |
| 04/26/2006 | EP1650225A1 Hetero type pentamer recombinant vaccine |
| 04/26/2006 | EP1650224A1 Composition and method for repairing nerve damage and enhancing functional recovery of nerve |
| 04/26/2006 | EP1650223A2 Rad51-brc repeat crystals |
| 04/26/2006 | EP1650221A2 Novel compounds |
| 04/26/2006 | EP1650219A1 Human toll homologues |
| 04/26/2006 | EP1650188A1 Treatment of tumors with RAR alpha selective retinoid compounds in combination with other anti-tumor agents |
| 04/26/2006 | EP1649746A1 MSH5 ablated mice and uses therefor |
| 04/26/2006 | EP1649053A2 Characterization of the earliest stages of the severe acute respiratory syndrome (sars) virus and uses thereof |
| 04/26/2006 | EP1649020A1 Synthetic gene encoding human epidermal growth factor 2/neu antigen and uses thereof |
| 04/26/2006 | EP1649002A2 Rna processing protein complexes and uses thereof |
| 04/26/2006 | EP1648998A2 Specific binding agents to hepatocyte growth factor |
| 04/26/2006 | EP1648939A2 Anti-vegf antibodies |
| 04/26/2006 | EP1648938A1 Bcl-2 splicing variants |
| 04/26/2006 | EP1648937A1 Product and composition containing a concholepas concholepas hemocyanin (cch) subunit a, and a method of use thereof |
| 04/26/2006 | EP1648936A1 Compositions and methods relating to multimeric and oligomeric soluble fragments of the tweak receptor |
| 04/26/2006 | EP1648935A2 Antagonists and agonists of ldcam and methods of use |
| 04/26/2006 | EP1648934A2 Pharmaceutical composition comprising cyclic somatostatin analogues |
| 04/26/2006 | EP1648933A1 Long lasting insulin derivatives and methods thereof |
| 04/26/2006 | EP1648932A2 Il-11 muteins |
| 04/26/2006 | EP1648931A2 Novel multifunctional cytokines |
| 04/26/2006 | EP1648930A1 Method of peptide synthesis |
| 04/26/2006 | EP1648929A2 Active subfragments of human histidine rich glycoprotein |
| 04/26/2006 | EP1648927A1 Soluble fragments of the sars-cov spike glycoprotein |
| 04/26/2006 | EP1648926A1 Glut-1 as a receptor for htlv envelopes and its uses |
| 04/26/2006 | EP1648920A2 Car ligand-binding domain polypeptide co-crystallized with a ligand, and methods of designing ligands that modulate car activity |
| 04/26/2006 | EP1648918A2 Non-glycosylated human alpha-fetoprotein, methods of production, and uses thereof |
| 04/26/2006 | EP1648917A2 Agonist polypeptide of receptor for zot and zonulin |
| 04/26/2006 | EP1648521A1 Compositions and methods for treating cardiac dysfunction |
| 04/26/2006 | EP1648503A2 Active or passive immunization against proapoptotic neurotrophins for the treatment or prevention of neurodegenerative deseases |
| 04/26/2006 | EP1648502A2 Hcv vaccines |
| 04/26/2006 | EP1648501A1 Hybrid toxins comprising shiga-like toxin subunits fused to escherichia coli heat labile enterotoxin subunits and vaccines thereof |
| 04/26/2006 | EP1648500A2 Immunogenic compositions for streptococcus pyogenes |
| 04/26/2006 | EP1648499A2 P. aeruginosa mucoid exopolysaccharide specific binding peptides |
| 04/26/2006 | EP1648490A2 Peptides and peptidomimetics having immune-modulating, anti-inflammatory, and anti-viral activity |
| 04/26/2006 | EP1648488A2 Human mast cell-expressed membrane protein |
| 04/26/2006 | EP1648477A2 Injection of bone marrow-derived cells and medium for angiogenesis |
| 04/26/2006 | EP1648388A2 Novel targets and compositions for use in decontamination, immunoprophylaxis, and post-exposure therapy against anthrax |
| 04/26/2006 | EP1648233A2 Mutants of vaccinia virus as oncolytic agents |
| 04/26/2006 | EP1648223A1 Npc1l1 (npc3) and methods of use thereof |
| 04/26/2006 | EP1571901A4 Generation of plants with altered oil content |
| 04/26/2006 | EP1515601A4 Nucleic acid sequences and methods of use for the production of plants with modified polyunsaturated fatty acids |
| 04/26/2006 | EP1499731A4 Modified pituitary gland development in offspring from expectant mother animals treated with growth hormone releasing hormone therapy |
| 04/26/2006 | EP1474521B1 An herpes simplex virus complex |
| 04/26/2006 | EP1472347A4 Improved protein expression in bacillus subtilis |
| 04/26/2006 | EP1421377B1 The natural ligand for orphan g protein coupled receptor gpr86 and methods of use |
| 04/26/2006 | EP1412508B1 Molecular vector for the genophenotypic characterisation of v3 sequences of hiv-1 gp120 |
| 04/26/2006 | EP1402039B1 MUTANT FORMS OF EtxB AND CtxB AND THEIR USE AS CARRIERS |
| 04/26/2006 | EP1368478B1 Polypeptide inducing hiv-neutralising antibodies |
| 04/26/2006 | EP1244702B1 Process for isolation of osteopontin from milk |
| 04/26/2006 | EP1218514B1 Designing immunogens |
| 04/26/2006 | EP1187918B1 Tek antagonists |
| 04/26/2006 | EP1105466B1 Process for purifying human papillomavirus virus-like particles |
| 04/26/2006 | EP1056779B1 Method for producing a factor viii/von willebrand factor complex |
| 04/26/2006 | EP1049788B1 Protein expression in baculovirus vector expression systems |
| 04/26/2006 | EP1015592B1 Bacillus thuringiensis cryet33 and cryet34 compositions and uses therefor |
| 04/26/2006 | EP1009829B1 Adipocyte-specific protein homologs |
| 04/26/2006 | EP0986759B1 Use of a fluorescent protein for detecting the interaction between a membrane receptor and its ligand |
| 04/26/2006 | EP0966536B1 Factor x analogues with a modified protease cleavage site |
| 04/26/2006 | EP0908466B1 Anti-human lect2 antibody, cells producing the same, and method and kit for assaying the same |
| 04/26/2006 | EP0850305B1 Compounds and methods for diagnosis of tuberculosis |
| 04/26/2006 | EP0848614B1 Isolation of microdomains of caveolae and gpi-anchored proteins |
| 04/26/2006 | EP0797672B8 Use of a sec-dependent secretion system for secreting proteins that are usually secreted by a sec-independent secretion system |
| 04/26/2006 | EP0784686B1 Herpes simplex virus glycoprotein d variants |
| 04/26/2006 | EP0773997B1 Htk ligand |